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Abstract
Objective:  the  present  study  was  conducted  to  investigate  the  oxidant-antioxidant  status  in
Egyptian  children  with  sickle  cell  anemia.
Methods:  the  serum  levels  of  total  antioxidant  capacity  (TAO),  paraoxonase  (PON),  vitamin  E,
nitrite,  and  malondialdehyde  (MDA)  were  measured  in  40  steady  state  children  with  homozygous
sickle  cell  anemia  (24  males  and  16  females)  and  20  apparently  healthy  age-  and  gender-
matched  controls.
Results: mean  serum  TAO,  PON,  vitamin  E,  and  nitrite  levels  were  signiﬁcantly  lower  in  the
group  with  sickle  cell  anemia,  whereas  mean  serum  MDA  was  signiﬁcantly  higher  in  these  chil-
dren  compared  to  controls.  No  signiﬁcant  differences  in  mean  levels  of  TAO,  PON,  nitrite,
vitamin  E,  and  MDA  were  found  in  sickle  cell  anemia  patients  receiving  hydroxyurea  when  com-
pared  with  those  not  receiving  hydroxyurea.  A  signiﬁcant  negative  correlation  between  serum
nitrite  and  the  occurrence  of  vaso-occlusive  crises  (VOC)  was  observed  (r  =  −0.3,  p  =  0.04).  PON
level  was  found  to  be  positively  correlated  with  patients’  weight  and  BMI  (r  =  −0.4,  p  =  0.01;
r =  −0.7,  p  <  0.001,  respectively),  but  not  with  frequency  of  VOC.  The  area  under  the  curve  of
serum  nitrite  in  predicting  occurrence  of  VOC  was  0.782,  versus  0.701  for  PON,  and  0.650  for
TAO  (p  =  0.006).  Serum  MDA  was  not  correlated  with  nitrite,  PON,  TAO,  or  vitamin  E  levels.  No
signiﬁcant  correlations  were  detected  between  serum  nitrite  and  hemoglobin  or  antioxidant
enzymes.
Conclusion:  children  with  sickle  cell  anemia  have  chronic  oxidative  stress  that  may  result  in
increased VOC,  and  decreased  serum  nitrite  may  be  associated  with  increases  in  VOC  frequency.
A  novel  ﬁnding  in  this  study  is  the  decrease  in  PON  level  in  these  patients,  which  is  an  interesting
subject  for  further  research.
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Estado  oxidante-antioxidante  em  crianc¸as  egípcias  com  anemia  falciforme:  estudo
baseado  em  um  único  centro
Resumo
Objetivo:  o  presente  estudo  foi  realizado  com  o  objetivo  de  investigar  o  estado  oxidante-
antioxidante em  crianc¸as  egípcias  com  anemia  falciforme.
Métodos:  dosamos  os  níveis  séricos  da  capacidade  antioxidante  total  (CAT),  paraoxonase  (PON),
vitamina  E,  nitrito  e  malondialdeído  (MDA)  em  40  crianc¸as  estáveis  com  anemia  falciforme
homozigótica  (24  meninos  e  16  meninas),  e  20  controles  pareados  por  idade/sexo  aparente-
mente  saudáveis.
Resultados:  os  níveis  séricos  médios  da  CAT,  PON,  vitamina  E  e  nitrito  foram  signiﬁcativa-
mente menores,  ao  passo  que  o  nível  sérico  médio  de  MDA  foi  signiﬁcativamente  maior  em
crianc¸as  com  anemia  falciforme  (AF),  em  comparac¸ão  aos  controles.  Não  foram  encontradas
diferenc¸as  signiﬁcativas  nos  níveis  médios  de  CAT,  PON,  nitrito,  vitamina  E  e  MDA  em  pacientes
com  AF  em  tratamento  com  hidroxiureia,  em  comparac¸ão  aos  que  receberam  hidroxiureia.
Encontramos uma  correlac¸ão  negativa  signiﬁcativa  entre  o  nitrito  sérico  e  a  ocorrência  de
crises  vaso-oclusivas  agudas  (CVO)  (r  =  −0,3,  p  =  0,04).  Descobrimos  que  o  nível  de  PON  está
correlacionado  positivamente  com  o  peso  e  o  IMC  dos  pacientes  (r  =  −0,4;  p  =  0,01;  r  =  −0,7;
p <  0,001,  respectivamente),  porém  não  com  a  frequência  de  CVO.  A  área  sob  a  curva  (ASC)  do
nitrito  sérico  na  previsão  da  ocorrência  de  CVO  foi  0,782,  em  comparac¸ão  a  0,701  para  PON  e
0,650  para  CAT  (p  =  0,006).  O  MDA  não  está  correlacionado  a  nitrito,  PON,  CAT  ou  vitamina  E.
Não  foram  detectadas  correlac¸ões  signiﬁcativas  entre  nitrito  sérico  e  hemoglobina  ou  enzimas
antioxidantes.
Conclusão:  crianc¸as  com  AF  apresentam  estresse  oxidativo  crônico  que  pode  resultar  em
aumento das  CVO.  Em  crianc¸as  com  AF,  a  reduc¸ão  nos  níveis  de  nitrito  sérico  pode  estar  asso-
ciada  a  aumentos  da  frequência  de  CVO.  Um  novo  achado  neste  estudo  é  a  reduc¸ão  no  nível  de
PON  em  pacientes  com  AF,  que  é  um  campo  interessante  de  novas  pesquisas.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Sickle  cell  anemia  (SCA)  is  one  of  the  most  common  mono-
genic disorders  in  the  world,  predominantly  observed  in
Africa and  Southeast  Asia.  It  is  a  multi-system  disease,  asso-
ciated with  episodes  of  acute  illness  and  progressive  organ
damage.1 SCA  results  from  a  p  mutation  in  the  genetic
code such  that  glutamic  acid  is  replaced  by  valine  in  the
globin chain  of  hemoglobin.  This  substitution  transforms  nor-
mal adult  hemoglobin  (HbA)  into  sickle  hemoglobin  (HbS).
When deoxygenated,  HbS  polymerizes,  and  when  a  crit-
ical amount  of  HbS  polymer  accumulates  within  a  sickle
erythrocyte, cellular  injury  occurs.  A  sufﬁcient  number
of damaged  erythrocytes  cause  the  phenotype  of  sickle
cell disease  (SCD),  characterized  by  hemolytic  anemia  and
vasoocclusion.2
SCD  is  emerging  as  an  important  model  of  oxidative
stress. Since  red  blood  cells  (RBCs)  carry  oxygen  to  the  body
tissues, they  are  already  rich  in  oxidative  fuel.  Their  distinc-
tive structural  features  make  them  susceptible  to  an  oxidant
assault. Chronic  oxidative  stress  resulting  from  an  imbal-
ance between  the  production  of  reactive  oxidant  species
(ROS) and  antioxidant  enzymes  constitutes  a  critical  fac-
tor in  endothelial  dysfunction,  inﬂammation,  and  multiple
organ damage  in  SCD.  In  addition,  the  disease  is  character-
ized by  damage  to  the  cell  membrane  due  to  increased  lipid
peroxidation products,  such  as  malondialdehyde  (MDA)  and
the increased  consumption  of  nitric  oxide  (NO).3,4
M
T
NIncreased  ROS  production  is  caused  by  intrinsic  mecha-
isms of  disease,  such  as  increased  activity  of  several  oxi-
ases (NADPH  oxidase  and  endothelial  xanthine  oxidase),5
uto-oxidation  of  HbS,  release  of  heme  iron,  increased
symmetric dimethylarginine,6 uncoupling  of  NO  synthase
ctivity, and  decreased  NO  levels.7 This  enhanced  produc-
ion of  free  radicals  in  SCA  and  subsequent  decreased  NO
ioavailability inactivate  NO-mediated  vascular  relaxation.8
mpaired  vascular  relaxation  and  increased  endothelial
dherence contribute  to  the  vaso-occlusive  phenomena.9
Several  reports  indicate  that  SCA  patients  have  lower
evels of  antioxidants  such  as  NO,  total  antioxidant  capac-
ty (TAO),  and  vitamin  E  as  compared  to  normal  healthy
ontrols.10--13 Moreover,  one  study  showed  a  signiﬁcantly
nhanced lipid  peroxidation  in  SCA  patients  when  compared
o controls.14 However,  limited  studies  have  evaluated  the
ole of  oxidants  and  antioxidant  status  in  children  with  SCA.
o the  authors’  knowledge,  none  have  been  conducted  in
atients with  SCD  in  Egypt.  The  present  study  aimed  to  eval-
ate the  oxidant-antioxidant  status  in  Egyptian  children  with
CA in  a steady  state  through  the  estimation  of  serum  levels
f the  lipid  peroxidation  product  MDA,  nitrite,  PON,  vitamin
, and  TAO.aterial and methods
his  was  a prospective  case-control  study  conducted  at  the
ew Children’s  Hospital  of  Cairo  University,  Egypt,  and  at
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he  Child  Health  and  Medical  Biochemistry  Departments
f the  National  Research  Center,  Cairo,  Egypt.  Forty  chil-
ren with  established  diagnosis  of  homozygous  (HbSS)  SCA
24 males  and  16  females  aged  10.6  ±  4.5  years)  and  20
ealthy subjects  (age-  and  gender-matched  controls,  12
ales and  8  females  aged  10.0  ±  2.8  years  [p  >  0.05])  were
nrolled in  the  study  after  their  legal  guardians  signed  the
nformed consent.  All  recruited  patients  were  in  a  steady
tate attending  routine  follow-up  during  the  study  period
from December  1,  2011  to  June  30,  2012).  Patients  aged  >
8 years,  those  with  acute  febrile  illness  within  72  hours,  or
cute vaso-occlusive  crises  (VOC)  within  three  months  prior
o enrollment,  serious  concurrent  illness,  and  those  assigned
o a  regular  blood  transfusion  program  were  excluded.  None
f recruited  subjects  received  supplemental  antioxidants  or
itamins e.g.  vitamin  E.  The  study  protocol  was  approved
y the  Ethics  Committee  of  the  Cairo  University  and  by  the
thics Committee  of  the  National  Research  Center,  Cairo,
gypt, according  to  the  Institutional  Committee  for  the  Pro-
ection of  Human  Subjects,  and  adopted  by  the  18th  World
edical Assembly,  Helsinki,  Finland.
Detailed  history-taking  and  thorough  clinical  examina-
ions were  performed.  At  enrollment,  the  number  of  severe
ainful episodes  in  the  preceding  12  months  was  recorded
frequency of  VOC  per  year),  with  a  working  deﬁnition  of  a
OC as  pain  in  the  extremities,  back,  abdomen,  chest,  or
ead that  led  to  an  unscheduled  clinic  or  emergency  room
isit and  required  hospitalization,  and  that  could  only  be
xplained by  SCD,  with  exclusion  of  hand-foot  syndrome,
hest syndrome,  osteomyelitis,  and  any  episode  of  pain  that
as treated  entirely  at  home.15
Thirty-one  patients  were  on  hydroxyurea  (HU)  therapy
ith a  mean  dose  of  19.8  ±  3.4  (range  15--30  mg/kg/day,
iven orally  once  a  day).  The  mean  duration  of  HU  was
.12 ±  1.49  years.  Dose  escalation  was  guided  by  clinical  and
ematological response  with  no  attempt  to  reach  the  maxi-
um tolerated  dose  (MTD);16 3  subjects  were  at  MTD  at  time
f enrollment.
Blood samples  for  determination  of  MDA,  nitrite,  PON,
AO, and  vitamin  E  were  collected  and  processed  as  follows:
 mL  of  blood  were  collected  into  plain  tubes  and  allowed  to
lot for  30  min  at  25 ◦C;  it  was  then  centrifuged  at  3,000  rpm
or 15  min  at  4 ◦C,  and  the  serum  was  separated  into  clean,
roperly labeled  tubes  for  analysis.
Determination  of  lipid  peroxidation:  Lipid  peroxidation
as assayed  by  measuring  the  level  of  MDA.  It  was  deter-
ined by  measuring  thiobarbituric  reactive  species  using
he method  of  Ruiz-Larrea  et  al.,17 in  which  the  thiobarbi-
uric acid-reactive  substances  react  with  thiobarbituric  acid
o produce  a  red  colored  complex  with  peak  absorbance  at
32 nm.
Determination  of  serum  nitrite:  Serum  nitrite  (NO2−),  as
n acceptable  surrogate  marker  to  serum  NO,  was  measured
sing Griess  reagent,  following  the  Moshage  et  al.  method;18
itrite,  a  stable  end-product  of  NO  radical,  is  commonly  used
s indicator  for  the  production  of  NO.19
Determination  of  PON  activity:  Arylesterase  activity  of
ON was  measured  spectrophotometrically  in  supernatants
sing phenylacetate  as  a  substrate.20
Measurement  of  serum  TAO  levels:  Serum  TAO  levels
ere determined  using  an  automated  measurement  method,
hich is  based  on  the  bleaching  of  the  characteristic  color
t
v
wEl-Ghamrawy  MK  et  al.
f  a  more  stable  2,  2-azino-bis  (3-ethylbenz-thiazoline-
-sulfonic  acid,  [ABTS])  radical  cation  by  antioxidants
Beckman Coulter  -  Fullerton,  CA,  USA).21 The  ABTS  radi-
al cation  is  decolorized  by  antioxidants  according  to  their
oncentrations and  antioxidant  capacities.  The  results  are
xpressed in  mmol  Trolox  equivalents/L.
Measurement  of  vitamin  E:  Vitamin  E as  tocopherol  was
easured by  HPLC.22 Freshly-obtained  erythrocytes  were
tored in  2%  pyrogallol  in  ethanol  at  -70 ◦C.  All  samples  were
nalyzed within  one  month  of  storage  using  a  reverse-phase
-18 column  (Waters  -  Milford,  MA,  USA),  a  95%  methanol
olvent system,  and  a  UV/VIS  detector  set  at  292  nm.22
tatistical  analysis
atients’  data  were  analyzed  using  the  Statistical  Package
or Social  Sciences  (SPSS),  version  17.0  for  Windows.
uantitative variables  were  expressed  by  mean  ±  standard
eviation (SD),  and  compared  using  Student’s  t-test  for
npaired samples  and  Mann--Whitney’s  test.  Spearman’s
ank-order test  was  used  for  correlating  quantitative
ariables. Qualitative  variables  were  expressed  as  num-
ers (frequency)  and  percentages,  and  compared  between
roups using  the  chi-squared  test.  Logistic  regression  anal-
sis  was  performed,  and  accuracy,  sensitivity,  speciﬁcity,
ositive predictive  value  (PPV),  and  negative  predictive
alue (NPV)  were  calculated.  A  receiver  operating  charac-
eristic (ROC)  curve  was  made,  and  area  the  under  the  curve
AUC) was  calculated.  The  optimal  cut-off  was  determined
or the  variables  required.  p-value  was  considered  to  be
igniﬁcant if  <  0.05.
esults
able  1  illustrates  a  comparison  of  the  tested  variables
etween SCA  patients  and  the  control  group.  Mean  values
f nitrite,  PON,  TAO,  and  vitamin  E  were  signiﬁcantly  lower,
hile the  MDA  level  was  signiﬁcantly  higher  in  SCA  patients
han in  control  group.  This  statistically  signiﬁcant  difference
n all  measured  variables  was  also  observed  when  com-
arison was  made  between  patients  and  gender-matched
ontrols. Gender  did  not  appear  to  affect  the  oxidant-
ntioxidant status  of  SCA  patients;  there  were  no  signiﬁcant
ifferences in  the  mean  levels  of  nitrite,  PON,  TAO,  and  MDA
n SCD  males  and  females  (Table  1).
No  signiﬁcant  differences  in  the  mean  levels  of  nitrite,
ON, TAO,  and  MDA  were  observed  between  SCD  patients
n HU  therapy  and  those  not  receiving  HU  (Table  2).  Com-
ared to  the  mean  vitamin  E  level  in  studied  controls,  the
revalence of  vitamin  E deﬁciency  among  SCA  patients  was
00%.
No signiﬁcant  correlations  were  detected  between  the
requency of  VOC  and  levels  of  MDA,  vitamin  E,  PON,  or
AO (p  >  0.05).  However,  serum  nitrite  correlated  negatively
ith the  frequency  of  VOC  (r  =  -0.3,  p  =  0.04),  but  did  not
orrelate with  the  levels  of  hemoglobin,  MDA,  PON,  TAO,
r vitamin  E  (r  =  0.19,  -0.3,  0.08,  0.03,  and  0.05,  respec-
ively, p  >  0.05).  MDA  did  not  correlate  with  any  of  the  tested
ariables, including  PON,  TAO,  and  vitamin  E  (p  >  0.05).
PON level  was  found  to  correlate  positively  with  patients’
eight and  BMI  (r  =  -0.4,  p  =  0.01;  r  =  -0.7,  p  <  0.001,
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Table  1  Comparison  of  serum  malondialdehyde,  nitrite,  paraoxonase,  total  antioxidant  capacity,  and  vitamin  E  in  sickle  cell
anemia  patients  and  controls.
Variables  SCA  cases  (n  =  40)  Controls  (n  =  20)  p-value
Mean  ±  SD  Range  Mean  ±  SD  Range
MDA  (nmol/mL) 2.56 ±  0.34 2--3.2 0.84 ±  0.04 0.79--0.91 0.0001a
Nitrite  (um/mL)  8.61  ±  1.1  6.6--11.7  13.88  ±  2.29  9.78--17.30  0.0001a
PON  (u/mL)  191.33  ±  33.19  108--269  247.8  ±  24.7  206--292  0.0001a
TAO  (mmol/L)  0.87  ±  0.10  0.56--0.99  1.03  ±  0.10  0.88--1.2  0.0001a
Vitamin  E(mg/mL)  0.174  ±  0.123  0.005--0.400  0.580  ±  0.259  0.10--0.90  0.0001a
Variables  Males  p-value  Females  p-value
Cases  (n  =  24) Controls  (n  =  12) Cases  (n  =  16) Control  (n  =  8)
Mean  ±  SD  Mean  ±  SD  Mean  ±  SD  Mean  ±  SD
MDA  (nmol/mL)  2.62  ±  0.34  0.85  ±  0.05  0.0001a 2.46  ±  0.34  0.83  ±  0.02  0.0001a
Nitrite  (um/mL)  8.67  ±  1.07  14.48  ±  1.3  0.0001a 8.51  ±  1.17  12.98  ±  3.1  0.005a
PON  (u/mL)  188.08  ±  36.2  236.83  ±  18.8  0.0001a 196.1  ±  28.4  264.2  ±  24.1  0.0001a
TAO  (mmol/L)  0.87  ±  0.08  1.04  ±  0.11  0.0001a 0.87  ±  0.12  1.02  ±  0.09  0.005a
Vitamin  E  (mg/mL)  0.185  ±  0.131  0.417  ±  0.175  0.001a 0.158  ±  0.112  0.825  ±  0.139  0.0001a
Variables  SCA  patients  (n  =  40)  p-value
Male  Cases  (n  =  24)  Female  cases  (n  =  16)
Mean  ±  SD Range  Mean  ±  SD Range
MDA  (nmol/mL)  2.6  ±  0.34  2.1--3.2  2.4  ±  0.34  2--3.1  0.17
Nitrite  (um/mL)  8.67  ±  1.07  6.9--11.7  8.5  ±  1.17  6.6--9.9  0.67
PON  (u/mL)  188.08  ±  36.2  108--269  169.19  ±  28.4  129--243  0.46
TAO  (mmol/L)  0.87  ±  0.08  0.71--0.9  0.87  ±  0.12  0.56--0.98  0.91
Vitamin  E  (mg/mL)  0.185  ±  0.131  0.005--0.400  0.158  ±  0.112  0.01--0.40  0.580
a; SD
i
i
ﬁ
t
t
oMDA, malondialdehyde; PON, paraoxonase; SCA, sickle cell anemi
a Statistically signiﬁcant value.
respectively).  No  signiﬁcant  correlations  were  observed
between serum  PON  and  frequency  of  VOC;  laboratory
indices of  hemolysis  including  hemoglobin,  reticulocyte
count, or  lactate  dehydrogenase;  or  with  levels  of  MDA,
nitrite, vitamin  E,  or  TAO  (p  >  0.05)  (Table  3).
Figure 1  presents  the  sensitivity  and  speciﬁcity  of  nitrite,
PON, and  TAO  in  predicting  the  occurrence  of  VOC  at  differ-
ent cut-off  values.  As  there  is  no  gold  standard  to  compare
with, nitrite,  PON,  and  TAO  were  compared  by  ROC  curve.
The AUC  of  nitrite  (0.782)  was  signiﬁcantly  higher  when  com-
pared  to  that  of  PON  (0.701)  and  TAO  (0.650)  (p  =  0.006),
D
T
n
Table  2  Comparison  of  serum  malondialdehyde,  nitrite,  paraoxo
anemia  patients  receiving  HU  and  those  not  receiving  HU.
Variables  SCA  cases  receiving  HU  (n  =  31)  
Mean  ±  SD  Range  
MDA  (nmol/mL) 2.55  ±  0.34  2--3.2  
Nitrite  (um/mL)  8.67  ±  0.94  6.6--10.1  
PON  (u/mL)  186.6  ±  30.9  108--240  
TAO  (mmol/L)  0.88  ±  0.09  0.63--0.9  
Vitamin  E  (mg/mL)  0.17  ±  0.127  0.005--0.4  
HU, hydroxyurea; MDA, malondialdehyde; PON, paraoxonase; SCA, sic
capacity., standard deviation; TAO, total antioxidant capacity,
ndicating  that  the  overall  predictability  of  nitrite  is  signif-
cantly higher  than  that  of  to  PON  or  TAO.  However,  when
xing the  sensitivity  or  speciﬁcity  of  nitrite,  it  was  found
hat either  its  sensitivity  or  speciﬁcity  became  unsatisfac-
ory; this  makes  its  adoption  as  a  good  predictor  of  the
ccurrence of  VOC  unlikely.iscussion
he  present  data  showed  that  there  were  decreases  in  serum
itrite, PON,  TAO,  and  vitamin  E  levels  in  SCA  children,  as
nase,  total  antioxidant  capacity,  and  vitamin  E  in  sickle  cell
SCA  cases  not  receiving  HU  (n  =  9)  p-value
Mea  ±  SD  Range
2.57  ±  0.37  2.1--3.1  0.91
8.39  ±  1.57  6.9--11.7  0.51
207.3  ±  37.6  148--269  0.10
0.82  ±  0.12  0.56--0.93  0.08
0.19  ±  0.12  0.01--0.4  0.583
kle cell anemia; SD, standard deviation; TAO, total antioxidant
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Table  3  Correlations  of  PON  level  and  patients’  clinical
and laboratory  variables.
r-coefﬁcient  p-value
Age  (years)  0.24  0.13
Age at  diagnosis  (years)  0.30  0.06
VOC frequency  (times/year)  −0.21  0.20
Weight (kg)  0.404  0.010a
BMI  (kg/m2) 0.67 < 0.001a
Hemoglobin  (g/dL) 0.17 0.30
Reticulocyte  (%) −0.058 0.723
LDH (U/L) 0.247 0.125
MDA  (nmol/mL)  −0.26  0.10
Nitrite (um/mL)  0.08  0.63
TAO (mmol/L)  −0.136  0.402
Vitamin E  (mg/mL)  −0.08  0.62
BMI, body mass index; LDH, lactate dehydrogenase; MDA, malon-
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wdialdehyde; PON, paraoxonase; TAO, total antioxidant capacity;
VOC,  vaso-occlusive crises.
a Statistically signiﬁcant values.
ell  as  an  increase  in  oxidative  stress  represented  by  MDA
evel. Gender  and  HU  therapy  did  not  appear  to  affect  the
xidant-antioxidant status  of  SCA  children.  Serum  nitrite
as the  only  marker  that  correlated  negatively  with  the  fre-
uency of  VOC.  The  overall  predictability  of  nitrite  in  VOC
ccurrence was  signiﬁcantly  higher  when  compared  to  PON
nd TAO,  but  an  increase  in  its  sensitivity  was  invariably
ccompanied by  a  concomitant  decrease  in  speciﬁcity.
Several  studies  have  observed  decreases  in  the  activity
evels of  nitrite,10--12 PON,  TAO,11,12 and  vitamin  E13 in  SCD
dult patients  in  steady  state.  Additionally,  increased  values
f MDA  as  a  lipid  peroxidation  product  were  reported  as  an
ndex of  the  generation  of  ROS  and  oxidative  stress  in  several
isorders, including  SCD.23 To  the  authors’  knowledge,  this
tudy was  the  ﬁrst  to  investigate  the  oxidant-antioxidant
tatus in  Egyptian  SCA  children  and  to  report  increased
xidative stress  in  children  with  SCD.
One  of  the  main  ﬁndings  of  the  present  study  is  that
he nitrite  level  was  comparable  in  males  and  females  with
CA. This  contradicts  previous  studies  reporting  reductions
f basal  and  stimulated  nitrite  production  and  responses  to
xogenous NO  in  male  patients  with  SCA  when  compared  to
Roc curve
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ig.  1  ROC  curve  of  nitrite,  PON,  and  TAO  for  prediction  of
ccurrence of  vaso-occlusive  crisis.
O, nitrite; PON, paraoxonase; ROC curve, receiver operating
haracteristic curve; TAO, total antioxidant capacity.
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emales.24 Nevertheless,  these  differences  disappear  when
nly children  are  considered.  Gender  differences  in  NO
ioavailability are  probably  caused  in  part  by  the  protec-
ive effects  of  ovarian  estrogen  on  NO  synthase  expression
nd activity  in  pubertal  females.24
HU  is  described  as  an  inducer  of  fetal  hemoglobin  expres-
ion, which  reduces  HbS  polymerization  in  SCA  patients,
educing mortality  and  VOC.25 In  vitro  and  animal  studies
ave demonstrated  that  HU  may  play  an  additional  role  as
 NO  donor.26 The  activation  of  fetal  hemoglobin  expres-
ion by  HU  may  occur  through  this  NO  pathway.27 Clinical
tudies suggested  an  antioxidant  effect  of  HU  on  SCA  by
easuring glutathione  levels  and  other  antioxidants  in  SCA
atients treated  with  HU  and  those  who  were  not  given  this
edication.28 However,  the  small  number  of  patients  who
ere not  receiving  HU  in  the  present  study  makes  it  dif-
cult to  draw  any  conclusions  regarding  the  effects  of  HU
whether direct  or  indirect)  on  the  measured  oxidant  and
ntioxidant markers.
The present  study  observed  a  weak  association  between
he decreases  in  serum  nitrite  level  and  increased  frequency
f VOC.  However,  no  correlations  of  serum  nitrite  level  with
aboratory indices,  such  as  total  hemoglobin  level,  other
ntioxidants, or  MDA  were  observed.
SCD  is  an  extremely  heterogeneous  disease  for  many
easons, and  the  occurrence  of  VOC  appears  to  be  multi-
actorial. Even  if  low  nitrite  is  one  of  these  factors,  it  is
mpossible to  conclude  that  serum  nitrite  level  may  provide
peciﬁc prognostic  or  clinical  information  beyond  that  given
y the  simple,  conventional  measurement  of  hemoglobin
oncentration. However,  it  may  be  reserved  as  a  simple
iomarker of  oxidative  stress  in  children  with  SCA  in  steady
tate to  help  in  selection  and  follow-up  of  those  in  need  for
ntioxidant supplements.
In the  present  study,  TAO  was  measured,  as  its  value
s more  informative  than  the  knowledge  of  individual
ntioxidant.12 Its  level  reﬂects  the  collective  contribution  to
he reducing  property  of  non-protein  individual  antioxidant
r electron  donating  components.  However,  no  correlation
as found  between  TAO  and  increased  frequency  of  VOC.
An  important  new  observation  in  the  present  study  was
he decrease  in  PON  level  in  SCA  children.  PON  level  was
ound to  increase  with  body  weight  and  BMI,  but  it  did  not
orrelate with  the  frequency  of  VOC  or  indicators  of  hemol-
sis. However,  and  to  the  authors’  knowledge,  there  are  no
eports on  PON  level  or  its  impact  on  the  phenotype  in  SCD
atients. PON  is  a  calcium-dependent  serum  esterase  that  is
ynthesized by  the  liver  and  is  released  into  the  circulation,
here it  associates  mainly  with  high-density  lipoproteins
nd protects  low-density  lipoproteins  and  cellular  mem-
ranes against  lipid  peroxidation.29 It  is  largely  believed  to
ave a  role  in  protection  against  oxidative  stress.30 Patients
ith coronary  heart  disease  showed  increased  lipid  peroxi-
ation and  decreased  PON  activity.31 This  may  suggest  that
atients with  SCA  who  showed  decreased  PON  and  increased
ipid peroxidation  (MDA)  may  be  at  risk  of  other  forms  of  vas-
ulopathy, including  coronary  heart  disease,  especially  with
rowing up  indicating  future  studies.
The  present  study  demonstrated  that  oxidative  stress  is
vident in  young  children  with  SCA.  Thus,  it  highlights  the
eed for  clinical  trials  examining  the  value  of  supplemen-
ation with  vitamin  E or  other  agents  that  increase  the  total
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antioxidant  capacity  among  these  children,  and  whether  this
may improve  their  clinical  course.
Children  with  SCA  have  chronic  oxidative  stress  that  may
result in  increased  VOC.  In  children  with  SCA,  decreased
serum nitrite  may  be  associated  with  increases  in  VOC  fre-
quency. A  novel  ﬁnding  in  this  study  was  the  decrease  in
PON levels  in  SCA  patients,  which  is  an  interesting  ﬁeld  for
further research.
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